STOCK TITAN

PTC Therapeutics officer proposes $178K share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

PTC Therapeutics, Inc. (PTCT) officer Mark Elliott Boulding gave notice of a proposed sale of 2,812 common shares, with an aggregate market value of $177,887.12 and an approximate sale date of November 16, 2026. The notice lists the shares as acquired from the issuer through a stock option exercise for cash on November 16, 2026. It gives September 10, 2025 as the date of plan adoption or instruction, if relying on Rule 10b5-1.

Proposed sale 2,812 common shares Approximate sale date: November 16, 2026
Aggregate market value $177,887.12 For the proposed sale
Shares outstanding 83,544,284 shares Number reported in the securities information
Shares acquired through stock option exercise 2,812 common shares November 16, 2026; cash payment
Earlier shares sold 2,813 shares August 17, 2026
Earlier shares sold 1,638 shares October 5, 2026
Earlier shares sold 435 shares October 6, 2026
Earlier shares sold 192 shares October 9, 2026
Rule 10b5-1 regulatory
"If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Stock Option Exercise financial
"Nature of Acquisition Transaction: Stock Option Exercise"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PTCT shares did Mark Elliott Boulding propose to sell?

Mark Elliott Boulding's notice reports a proposed sale of 2,812 common shares, with an aggregate market value of $177,887.12 and an approximate sale date of November 16, 2026.

How did Mark Elliott Boulding acquire the PTCT shares covered by the sale notice?

The reported 2,812 common shares were acquired from the issuer through a stock option exercise for cash on November 16, 2026.

What Rule 10b5-1 plan date is associated with Mark Elliott Boulding's PTCT sale?

The reported date is September 10, 2025, identified as the plan adoption or instruction date if relying on Rule 10b5-1.

What earlier PTCT sales did Mark Elliott Boulding report?

His reported common-stock sales were 2,813 shares on August 17, 2026 ($204,123.09 gross proceeds), 1,638 shares on October 5 ($104,883.43), 435 shares on October 6 ($27,907.59), and 192 shares on October 9 ($12,338.84).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading